Skip to content
Bored Studies
RecruitingPhase 2

Study to Evaluate the Safety and Efficacy of Ublituximab in Participants With Schizophrenia

TG Therapeutics, Inc. · NCT07680946

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18–60 · All sexes
Healthy volunteers
Not accepted (a condition is required)
Study type
Interventional · Phase 2
Target enrollment
60
US sites recruiting
2
Study start
July 27, 2026
Record last updated
September 23, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

The main objective of this Phase 2 study is to assess the efficacy of ublituximab as measured by Positive and Negative Syndrome Scale (PANSS) total score in participants with schizophrenia.

Being studied: Ublituximab

Conditions: Schizophrenia

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Primary diagnosis of schizophrenia.
  • Treatment-resistant.
  • Requires antipsychotic treatment and is currently receiving "standard of care".
  • PANSS total score between 80 and 120, inclusive at screening and baseline.

Exclusion Criteria

  • Any primary Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR) disorder other than schizophrenia.
  • Ongoing clozapine treatment.
  • Risk for suicidal behavior.
  • Any severe or uncontrolled medical condition that could affect the participant's ability to participate.

Note: Other protocol-specified Inclusion/Exclusion criteria may apply

Recruiting US locations

Study contacts (from the official record)

  • TG Therapeutics Clinical Support Team · 1-877-575-8489 · clinicalsupport@tgtxinc.com
All mental health studies in Arkansas →
Study to Evaluate the Safety and Efficacy of Ublituximab in… (NCT07680946) | Bored Studies